| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/30/2012 | CN102475714A 壳寡糖单一化合物在免疫增强药物中的应用 Oligochitosan single compounds in immune-enhancing drugs in |
| 05/30/2012 | CN102475708A 丙酸氟替卡松和含辅料的水构成的治疗皮肤病的分离式水混悬剂药物 Dermatology separate water fluticasone propionate and water containing materials constituting drug suspensions |
| 05/30/2012 | CN102475681A 治疗皮肤病的分离式水混悬剂药物 Dermatological separate aqueous suspensions of drug |
| 05/30/2012 | CN102133298B Two-aqueous-phase method for extracting total saponin from bittersweet herb |
| 05/30/2012 | CN102133289B Particle for protecting liver and beautifying skin |
| 05/30/2012 | CN102078367B Use of aidi preparation in preparation of medicaments for treating multiple organ dysfunction syndrome in elderly |
| 05/30/2012 | CN102078345B Preparation method of actinidia arguta flavonoids |
| 05/30/2012 | CN102048686B Application of yeast dextran injection for improving immune efficiency of foot-and-mouth disease vaccine of dairy cow |
| 05/30/2012 | CN102028849B Chinese medicinal composition and preparation method thereof |
| 05/30/2012 | CN102028725B Traditional Chinese medicine composition, extract, preparation method and application thereof |
| 05/30/2012 | CN101978975B Haematococcus extract preparation, and preparation method and use thereof |
| 05/30/2012 | CN101935624B Bacillus subtillis and method for preparing raw powder of each gram of bacillus subtillis with 1 trillion live germs |
| 05/30/2012 | CN101933949B Application of traditional Chinese medicine medicated leaven in lysozyme-liposome coated with chitosan |
| 05/30/2012 | CN101904863B Preparation process of medicinal composition compounded from astragaloside and astragalus polyose |
| 05/30/2012 | CN101891837B Carboxymethylation bifidobacterium exopolysaccharide, preparation method thereof and application thereof |
| 05/30/2012 | CN101884769B Traditional Chinese medicine for treating autoimmune thyroiditis and production method |
| 05/30/2012 | CN101849972B Banding detection method of Cordyceps sinensis DNA fingerprint high resolution ratio |
| 05/30/2012 | CN101837065B Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof |
| 05/30/2012 | CN101829056B Ligustilide fat emulsion and preparation method thereof |
| 05/30/2012 | CN101798347B Monoclonal antibody for resisting high mobility group protein B1 |
| 05/30/2012 | CN101780125B Medical application of garden balsam seed for preventing rheumatoid arthritis |
| 05/30/2012 | CN101773521B Method for purifying deer serum |
| 05/30/2012 | CN101760390B Production method of wine for keeping in good health |
| 05/30/2012 | CN101653576B Compound Chinese herbal medicine immune potentiator for turbot |
| 05/30/2012 | CN101612305B Aweto health-care wine and processing method thereof |
| 05/30/2012 | CN101570554B Method for preparing zinc supplementing agent carboxymethyl chitosan oligosaccharide zinc |
| 05/30/2012 | CN101547935B Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2012 | CN101502516B Glipizide enteric-coated formulation composition and method for preparing the same |
| 05/30/2012 | CN101480484B Method for preparing miraculous powder preparation of ledebouriella |
| 05/30/2012 | CN101415678B Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 05/30/2012 | CN101352498B Formulation for improving thirst, polyphagia, hypodynamia and polyuria of diabetes patients |
| 05/30/2012 | CN101325960B Use of lactobacillus for treatment of virus infections |
| 05/30/2012 | CN101292742B Health food for reinforcing immune function of human body and preparation technique thereof |
| 05/30/2012 | CN101288475B Production method of flavor panax ginseng |
| 05/30/2012 | CN101181227B Solid lipid nanometer particle in-situ gel rubber preparations of biological adherent cyclosporine A and preparation method thereof |
| 05/30/2012 | CN101061105B Potentiators of glutamate receptors |
| 05/29/2012 | US8188276 2,4-pyrimidinediamine compounds and their uses |
| 05/29/2012 | US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 05/29/2012 | US8188113 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/29/2012 | US8188100 Adenosine derivatives as A2A receptor agonists |
| 05/29/2012 | US8187630 Extended release oral dosage composition |
| 05/29/2012 | US8187610 Streptococcus equi strain |
| 05/29/2012 | US8187600 Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses |
| 05/29/2012 | US8187588 Mycoplasma hyopneumoniae bacterin vaccine |
| 05/29/2012 | CA2686525C An antihistamine antiallergic agent and a method of deriving it |
| 05/29/2012 | CA2684582C N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical compositioncomprising the same |
| 05/29/2012 | CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same |
| 05/29/2012 | CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 05/29/2012 | CA2495350C Use of lck inhibitor for treatment of immunologic diseases |
| 05/29/2012 | CA2482499C Aerosol containing a particulate active substance |
| 05/29/2012 | CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 05/29/2012 | CA2417389C Therapeutic polyesters and polyamides |
| 05/29/2012 | CA2377957C Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 05/29/2012 | CA2368855C Differentiation of monocytes into functional dendritic cells |
| 05/29/2012 | CA2338005C Peptide antagonists of zonulin and methods for use of the same |
| 05/29/2012 | CA2329148C Specific binding proteins for treating canine allergy |
| 05/29/2012 | CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 05/29/2012 | CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use |
| 05/29/2012 | CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists |
| 05/24/2012 | WO2012068470A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 05/24/2012 | WO2012068343A1 Quinoline derivatives as pik3 inhibitors |
| 05/24/2012 | WO2012067963A1 Nampt inhibitors |
| 05/24/2012 | WO2012066336A1 Benzylamine compounds as toll -like receptor 7 agonists |
| 05/24/2012 | WO2012066335A1 Phenol compounds als toll -like receptor 7 agonists |
| 05/24/2012 | WO2012065263A1 Immunogenic compositions |
| 05/24/2012 | WO2012065262A1 Expression, purification and refolding of recombinant chlamydia proteins, compositions and related methods |
| 05/24/2012 | WO2012065216A1 Signal transduction pathway modulation |
| 05/24/2012 | WO2012026712A3 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof |
| 05/24/2012 | WO2012015704A3 Peripherally restricted faah inhibitors |
| 05/24/2012 | WO2011153277A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 05/24/2012 | WO2011152671A9 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin |
| 05/24/2012 | US20120130350 Detection and treatment of autoimmune disorders |
| 05/24/2012 | US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
| 05/24/2012 | US20120129944 Stabilized composition comprising at least one adrenergic compound |
| 05/24/2012 | US20120129935 Nutrition with lipids and non-digestible saccharides |
| 05/24/2012 | US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 05/24/2012 | US20120129930 Ketone compounds and compositions for cholesterol management and related uses |
| 05/24/2012 | US20120129917 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 05/24/2012 | US20120129915 Organic compositions to treat hsf1-related diseases |
| 05/24/2012 | US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics |
| 05/24/2012 | US20120129906 Modulators of s1p receptors |
| 05/24/2012 | US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses |
| 05/24/2012 | US20120129867 Inhibitors of protein kinases |
| 05/24/2012 | US20120129866 Methods for preventing or treating metabolic diseases, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases or glaucoma |
| 05/24/2012 | US20120129864 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same |
| 05/24/2012 | US20120129853 Methods of treatment using selective bcl-2 inhibitors |
| 05/24/2012 | US20120129852 Azaindazoles as kinase inhibitors and use thereof |
| 05/24/2012 | US20120129849 Deuterated serine-threonine protein kinase modulators |
| 05/24/2012 | US20120129845 Inhibitors of Bruton's Tyrosine Kinase |
| 05/24/2012 | US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 05/24/2012 | US20120129829 Novel indole modulators of s1p receptors |
| 05/24/2012 | US20120129820 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| 05/24/2012 | US20120129814 Novel phosphonic acids as s1p receptor modulators |
| 05/24/2012 | US20120129813 Novel compounds as receptor modulators with therapeutic utility |
| 05/24/2012 | US20120129779 Tubulysine derivatives |
| 05/24/2012 | US20120129776 Bioactive peptides and method of using same |
| 05/24/2012 | US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 05/24/2012 | US20120128763 Lubricant for the ocular surface |
| 05/24/2012 | US20120128727 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
| 05/24/2012 | US20120128726 Infant feeding formulas comprising probiotic micro-organisms |